Comparison

gsk1292263

Item no. V1804-500mg
Manufacturer InvivoChem LLC
CASRN 1032823-75-8
Amount 500mg
Category
Type Biochemicals
Specific against other
ECLASS 5.1 32160401
ECLASS 6.1 32160405
ECLASS 8.0 32160490
ECLASS 9.0 32160490
ECLASS 10.0.1 32160490
ECLASS 10.1 32160490
ECLASS 11.0 32160490
UNSPSC 12000000
Available
Description
InvivoChem Cat #:V1804CAS #:1032823-75-8Purity >=98%

Description: GSK1292263 is a novel and potent GPR119 (G-protein-coupled receptor 119) agonist which has potential for the treatment of type 2 diabetes. It is currently undergoing phase 2 clinical trial for type 2 diabetes. GSK1292263 improves glucose regulation in animal models of diabetes, but has no effect on plasma glucose in type 2 diabetics. GSK1292263 treatment displayed little inhibition towards CYPs (CYP1A2, 2C9, 2C19, 2D6, 3A4), p-GP, OATP1B3, or OCT2. However, GSK1292263 inhibited BCRP and OATP1B1, which are transporters involved in statin disposition 1.

References: Eur J Med Chem. 2011 Jul; 46(7):2901-7; Xenobiotica. 2013 Jun; 43(6):498-508.

Molecular Weight (MW)
456.56
Formula
C23H28N4O4S
CAS No.
1032823-75-8
Storage
-20C for 3 years in powder form
-80C for 2 years in solvent
Solubility (In vitro)
DMSO: 34 mg/mL (74.5 mM)
Water: < 1 mg/mL
Ethanol:< 1 mg/mL
Solubility (In vivo)
30% Propylene glycol, 5% Tween 80, 65% D5W: 30 mg/mL
Synonyms
GSK1292263; GSK 1292263l; GSK-1292263

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 500mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close